Skip to main content
. 2018 Nov 2;15(4):348–355. doi: 10.1097/ICB.0000000000000825

Table 4.

Number of Injections in the Study Eye Before Month 12

Adolescent Patients
A* B C D E
Treatment received at Baseline, and Months 1 and 2 Baseline and Month 9 Baseline, and Months 1 and 3 Baseline and Month 1 Baseline, and Months 1, 2, 4, and 5
No. of injections 3 2 3 2 5
Mean 3
Range 2–5
*

Patient A also received four ranibizumab 0.5 mg injections in the fellow eye at Months 3, 4, 7, and 10 for CNV secondary to Best disease (the same CNV etiology as in the study eye).